ACADIA Pharmaceuticals, Inc.

NASDAQ: ACAD
$16.83
+$0.79 (+4.9%)
Closing price May 19, 2022
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Enphase Energy, General Motors, Incyte, Lyft, MP Materials, Newmont, Tenet Healthcare and Vale.
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer,...
Wednesday's early top analyst upgrades and downgrades included Biogen, Goodyear Tire, Hippo, Krispy Kreme, Lockheed Martin, Micron Technology, Microsoft, Nike and Patterson-UTI Energy.
Tuesday afternoon's top analyst upgrades and downgrades included Boot Barn, Cigna, Comerica, GoodRx, Oracle and United Rentals.
Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.
Thursday afternoon's analyst upgrades and downgrades included Deere, NetApp, Petrobras and TJX Companies.
JMP Securities has come out with a few stock picks that it thinks will outperform in the coming months.
Tuesday's top analyst upgrades and downgrades included Airbnb, Chevron, Coupang, Freeport-McMoRan, Peloton Interactive, Snap, Wynn Resorts and Zillow.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including DraftKings, H&R Block and Novartis.
Tuesday's top analyst upgrades and downgrades included AutoZone, Best Buy, Bloomin' Brands, EOG Resources, Lemonade, Micron Technology, QuantumScape, Stitch Fix and Twilio.
A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to the posted price targets and are best suited for patient, aggressive growth...
Health care has been a top performer this year, and there is every reason to believe that performance will carry through into 2021. These are four of the highest-ranked health care ideas from the...
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Chewy, DraftKings, Exxon Mobil, McAfee, Nvidia, Square, Tilray and Walt Disney.
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.